SU‐GG‐T‐465: Secondary Doses for the Treatment of Lung and Liver Cancers: IMRT vs. Proton Therapy

S. Kim, W. Kim, Y. Huh, Y. Kim, M. Kim, D. Hwang, S. Choi, Myonggeun Yoon

Research output: Contribution to journalArticle

Abstract

Purpose: To quantify and compare the secondary doses induced by advanced radiotherapy modalities, intensity‐modulated radiotherapy (IMRT) and proton beam therapy (PBT), for the treatment of lung and liver cancers. Method and Materials: IMRT with 6 MV photon and proton beam therapy were planned for 3 lung and 3 liver cancer patients. The treatment beams were delivered to phantom and corresponding secondary doses during irradiation were measured at various points from 20 cm to 50 cm apart from the beam isocenter using ion chamber and CR‐39 detectors for IMRT and PBT, respectively. Results: The average secondary doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 1.73 mSv/Gy to 0.86 mSv/Gy. The average secondary doses of IMRT for lung patients, however, ranged between 5.8 mSv/Gy and 1.0 mSv/Gy, approximately three times higher than for proton therapy. The average internal neutron doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 0.21 mSv/Gy to 0.08 mSv/Gy. The result shows that internal neutron dose produced by proton interaction in the body is generally much less than external neutron dose produced by proton interactions in the scattering elements of the passively modulated beam line. Conclusion: By a comparison between passive proton beam therapy and IMRT for diseases of lung and liver cancer, it was shown that the secondary doses using scattering mode in proton beam therapy is either significantly lower than the cases in IMRT treatment or, at least, does not exceed the secondary doses induced by conventional IMRT treatment.

Original languageEnglish
Pages (from-to)3293
Number of pages1
JournalMedical Physics
Volume37
Issue number6
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Proton Therapy
Liver Neoplasms
Lung Neoplasms
Radiotherapy
Neutrons
Therapeutics
Protons
Lung
Photons
Ions

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐GG‐T‐465 : Secondary Doses for the Treatment of Lung and Liver Cancers: IMRT vs. Proton Therapy. / Kim, S.; Kim, W.; Huh, Y.; Kim, Y.; Kim, M.; Hwang, D.; Choi, S.; Yoon, Myonggeun.

In: Medical Physics, Vol. 37, No. 6, 2010, p. 3293.

Research output: Contribution to journalArticle

Kim, S. ; Kim, W. ; Huh, Y. ; Kim, Y. ; Kim, M. ; Hwang, D. ; Choi, S. ; Yoon, Myonggeun. / SU‐GG‐T‐465 : Secondary Doses for the Treatment of Lung and Liver Cancers: IMRT vs. Proton Therapy. In: Medical Physics. 2010 ; Vol. 37, No. 6. pp. 3293.
@article{bf0303c004b74472ab1104ce768da345,
title = "SU‐GG‐T‐465: Secondary Doses for the Treatment of Lung and Liver Cancers: IMRT vs. Proton Therapy",
abstract = "Purpose: To quantify and compare the secondary doses induced by advanced radiotherapy modalities, intensity‐modulated radiotherapy (IMRT) and proton beam therapy (PBT), for the treatment of lung and liver cancers. Method and Materials: IMRT with 6 MV photon and proton beam therapy were planned for 3 lung and 3 liver cancer patients. The treatment beams were delivered to phantom and corresponding secondary doses during irradiation were measured at various points from 20 cm to 50 cm apart from the beam isocenter using ion chamber and CR‐39 detectors for IMRT and PBT, respectively. Results: The average secondary doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 1.73 mSv/Gy to 0.86 mSv/Gy. The average secondary doses of IMRT for lung patients, however, ranged between 5.8 mSv/Gy and 1.0 mSv/Gy, approximately three times higher than for proton therapy. The average internal neutron doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 0.21 mSv/Gy to 0.08 mSv/Gy. The result shows that internal neutron dose produced by proton interaction in the body is generally much less than external neutron dose produced by proton interactions in the scattering elements of the passively modulated beam line. Conclusion: By a comparison between passive proton beam therapy and IMRT for diseases of lung and liver cancer, it was shown that the secondary doses using scattering mode in proton beam therapy is either significantly lower than the cases in IMRT treatment or, at least, does not exceed the secondary doses induced by conventional IMRT treatment.",
author = "S. Kim and W. Kim and Y. Huh and Y. Kim and M. Kim and D. Hwang and S. Choi and Myonggeun Yoon",
year = "2010",
doi = "10.1118/1.3468863",
language = "English",
volume = "37",
pages = "3293",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐GG‐T‐465

T2 - Secondary Doses for the Treatment of Lung and Liver Cancers: IMRT vs. Proton Therapy

AU - Kim, S.

AU - Kim, W.

AU - Huh, Y.

AU - Kim, Y.

AU - Kim, M.

AU - Hwang, D.

AU - Choi, S.

AU - Yoon, Myonggeun

PY - 2010

Y1 - 2010

N2 - Purpose: To quantify and compare the secondary doses induced by advanced radiotherapy modalities, intensity‐modulated radiotherapy (IMRT) and proton beam therapy (PBT), for the treatment of lung and liver cancers. Method and Materials: IMRT with 6 MV photon and proton beam therapy were planned for 3 lung and 3 liver cancer patients. The treatment beams were delivered to phantom and corresponding secondary doses during irradiation were measured at various points from 20 cm to 50 cm apart from the beam isocenter using ion chamber and CR‐39 detectors for IMRT and PBT, respectively. Results: The average secondary doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 1.73 mSv/Gy to 0.86 mSv/Gy. The average secondary doses of IMRT for lung patients, however, ranged between 5.8 mSv/Gy and 1.0 mSv/Gy, approximately three times higher than for proton therapy. The average internal neutron doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 0.21 mSv/Gy to 0.08 mSv/Gy. The result shows that internal neutron dose produced by proton interaction in the body is generally much less than external neutron dose produced by proton interactions in the scattering elements of the passively modulated beam line. Conclusion: By a comparison between passive proton beam therapy and IMRT for diseases of lung and liver cancer, it was shown that the secondary doses using scattering mode in proton beam therapy is either significantly lower than the cases in IMRT treatment or, at least, does not exceed the secondary doses induced by conventional IMRT treatment.

AB - Purpose: To quantify and compare the secondary doses induced by advanced radiotherapy modalities, intensity‐modulated radiotherapy (IMRT) and proton beam therapy (PBT), for the treatment of lung and liver cancers. Method and Materials: IMRT with 6 MV photon and proton beam therapy were planned for 3 lung and 3 liver cancer patients. The treatment beams were delivered to phantom and corresponding secondary doses during irradiation were measured at various points from 20 cm to 50 cm apart from the beam isocenter using ion chamber and CR‐39 detectors for IMRT and PBT, respectively. Results: The average secondary doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 1.73 mSv/Gy to 0.86 mSv/Gy. The average secondary doses of IMRT for lung patients, however, ranged between 5.8 mSv/Gy and 1.0 mSv/Gy, approximately three times higher than for proton therapy. The average internal neutron doses of proton therapy for lung and liver cancer patients, measured 20 to 50 cm from the isocenter, ranged from 0.21 mSv/Gy to 0.08 mSv/Gy. The result shows that internal neutron dose produced by proton interaction in the body is generally much less than external neutron dose produced by proton interactions in the scattering elements of the passively modulated beam line. Conclusion: By a comparison between passive proton beam therapy and IMRT for diseases of lung and liver cancer, it was shown that the secondary doses using scattering mode in proton beam therapy is either significantly lower than the cases in IMRT treatment or, at least, does not exceed the secondary doses induced by conventional IMRT treatment.

UR - http://www.scopus.com/inward/record.url?scp=85024786655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024786655&partnerID=8YFLogxK

U2 - 10.1118/1.3468863

DO - 10.1118/1.3468863

M3 - Article

AN - SCOPUS:85024786655

VL - 37

SP - 3293

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -